Rapid infrared mapping for highly accurate automated histology in Barrett's oesophagus.

Barrett's oesophagus (BE) is a premalignant condition that can progress to oesophageal adenocarcinoma. Endoscopic surveillance aims to identify potential progression at an early, treatable stage, but generates large numbers of tissue biopsies. Fourier transform infrared (FTIR) mapping was used to develop an automated histology tool for detection of BE and Barrett's neoplasia in tissue biopsies. 22 oesophageal tissue samples were collected from 19 patients. Contiguous frozen tissue sections were taken for pathology review and FTIR imaging. 45 mid-IR images were measured on an Agilent 620 FTIR microscope with an Agilent 670 spectrometer. Each image covering a 140 μm × 140 μm region was measured in 5 minutes, using a 1.1 μm2 pixel size and 64 scans per pixel. Principal component fed linear discriminant analysis was used to build classification models based on spectral differences, which were then tested using leave-one-sample-out cross validation. Key biochemical differences were identified by their spectral signatures: high glycogen content was seen in normal squamous (NSQ) tissue, high glycoprotein content was observed in glandular BE tissue, and high DNA content in dysplasia/adenocarcinoma samples. Classification of normal squamous samples versus 'abnormal' samples (any stage of Barrett's) was performed with 100% sensitivity and specificity. Neoplastic Barrett's (dysplasia or adenocarcinoma) was identified with 95.6% sensitivity and 86.4% specificity. Highly accurate pathology classification can be achieved with FTIR measurement of frozen tissue sections in a clinically applicable timeframe.

[1]  Brian C. Wilson,et al.  Autofluorescence-Based Detection of Early Neoplasia in Patients with Barrett’s Esophagus , 2004, Digestive Diseases.

[2]  Christopher H Contag,et al.  Fiber-optic probes enable cancer detection with FTIR spectroscopy. , 2010, Trends in biotechnology.

[3]  A. Gavin,et al.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. , 2011, Journal of the National Cancer Institute.

[4]  Jin-guang Wu,et al.  Evaluation of Gallbladder Lipid Level During Carcinogenesis by an Infrared Spectroscopic Method , 2010, Digestive Diseases and Sciences.

[5]  J. Tijssen,et al.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. , 2014, JAMA.

[6]  B. Wilson,et al.  Characterization of tissue autofluorescence in Barrett's esophagus by confocal fluorescence microscopy. , 2007, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[7]  Thomas D. Wang,et al.  Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy , 2007, Proceedings of the National Academy of Sciences.

[8]  M. Diem,et al.  A decade of vibrational micro-spectroscopy of human cells and tissue (1994-2004). , 2004, The Analyst.

[9]  H. Barr,et al.  Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus , 2006, British Journal of Cancer.

[10]  Xuejun Sun,et al.  Fourier transform infrared microspectroscopy monitoring of 5-fluorouracil-induced apoptosis in SW620 colon cancer cells , 2014, Molecular medicine reports.

[11]  Jing Wang,et al.  FT-IR spectroscopic analysis of normal and cancerous tissues of esophagus. , 2003, World journal of gastroenterology.

[12]  Luca Quaroni,et al.  Characterization of Barrett esophagus and esophageal adenocarcinoma by Fourier-transform infrared microscopy. , 2009, The Analyst.

[13]  N. Marcon,et al.  Autofluorescence characterisation of isolated whole crypts and primary cultured human epithelial cells from normal, hyperplastic, and adenomatous colonic mucosa , 2005, Journal of Clinical Pathology.

[14]  Rebecca C Fitzgerald,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.

[15]  Hugh Barr,et al.  Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus , 2003, The Journal of pathology.

[16]  H. Sørensen,et al.  Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.

[17]  Chris Phillips,et al.  Digistain: a digital staining instrument for histopathology. , 2012, Optics express.